Frank L. Jaksch Jr.
Director · Niagen Bioscience, Inc.
- 2024
- Jun 26, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Frank L. Jaksch Jr. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ozan Pamir - $46K in NAGE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Frank L. Jaksch Jr.?
Frank L. Jaksch Jr. is a corporate insider, tracked as Director of Niagen Bioscience, Inc. (NAGE). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Frank L. Jaksch Jr. last file a Form 4?
The most recent primary Form 4 on record is dated 26 June 2026, one of 2 filings going back to 2024.
Has Frank L. Jaksch Jr. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($230K) across all tracked filings.
